OTC Healthcare in Tunisia
Euromonitor International's OTC Healthcare in Tunisia market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 96 | Publication date: Jun 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Positive growth for OTC healthcare
OTC healthcare continued to grow in current value terms in 2008. The positive performance of the overall market was attributable to general economic growth in Tunisia and a concomitant demographic transition. The rising purchasing power of consumers helped boost sales of OTC healthcare products.
Government regulations benefit local players producing under licence
Government controls on OTC healthcare in Tunisia continued to be strong. In 2008, the State continued to regulate prices and profit margins, as well as restricting imports towards the end of the review period. Partnerships between local and international players remained the only way for the latter to enter the market. Production of global brands under licence therefore intensified in 2008.
Multinational player leads
Bristol-Myers Squibb UPSA Tunisie led value sales in OTC healthcare in 2008, thanks to its dominance in analgesics, the largest OTC category in terms of value sales. The company’s Efferalgan and Fervex brands, which are globally established analgesics, were the leading brands in overall OTC healthcare in 2008. The company continued to gain share throughout the review period.
Chemists/pharmacies remains the only distribution channel
Sales of all OTC healthcare products in Tunisia continued to be limited to chemists/pharmacies during the review period. This was due to strict government controls over the sale of medicines. Aiming to reduce the misuse and self-medication of medicine, regulations are unlikely to be liberalised during the forecast period.
Government regulations to affect OTC sales
Increasing disposable incomes are expected to lead to further volume growth in OTC healthcare during the forecast period. Retail value sales, however, are expected pick up in comparison to both the review period and the performance in 2008. This is attributable to government controls on the distribution and pricing of OTC healthcare products and regulations on imports. Product developments will be limited to the leading players, which will continue to profit from cooperation with global partners.
Table of contents
OTC HEALTHCARE IN TUNISIA : MARKET INSIGHT
EXECUTIVE SUMMARY
Positive growth for OTC healthcare
Government regulations benefit local players producing under licence
Multinational player leads
Chemists/pharmacies remains the only distribution channel
Government regulations to affect OTC sales
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Generics
Switches
DEFINITIONS
Summary 1 Research Sources
ANALGESICS
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 11 Sales of Analgesics by Subsector: Value 2003-2008
Table 12 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 13 Herbal vs Standard Topical Analgesics 2003-2008
Table 14 Analgesics Company Shares by Value 2004-2008
Table 15 Analgesics Brand Shares by Value 2005-2008
Table 16 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 17 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 20 Sales of Decongestants by Type: Value 2003-2008
Table 21 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 22 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 24 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 25 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 27 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 29 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 30 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 31 Herbal vs Standard Digestive Remedies 2003-2008
Table 32 Digestive Remedies Company Shares by Value 2004-2008
Table 33 Digestive Remedies Brand Shares by Value 2005-2008
Table 34 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 35 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 36 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 37 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 38 Herbal vs Standard Medicated Skin Care 2003-2008
Table 39 Medicated Skin Care Company Shares by Value 2004-2008
Table 40 Medicated Skin Care Brand Shares by Value 2005-2008
Table 41 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 42 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN TUNISIA
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 43 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 44 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 45 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 46 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 47 Vitamins Brand Shares by Value 2005-2008
Table 48 Dietary Supplements Brand Shares by Value 2005-2008
Table 49 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 50 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Indicators
Table 51 Number of Smokers by Gender 2003-2008
Sector Data
Table 52 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 53 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 54 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 55 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 56 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 57 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
EYE CARE
Headlines
Sector Data
Table 58 Sales of Eye Care by Subsector: Value 2003-2008
Table 59 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 60 Eye Care Company Shares by Value 2004-2008
Table 61 Eye Care Brand Shares by Value 2005-2008
Table 62 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 63 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
WOUND TREATMENTS
Headlines
Sector Data
Table 64 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 65 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 66 Wound Treatments Company Shares by Value 2004-2008
Table 67 Wound Treatments Brand Shares by Value 2005-2008
Table 68 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 69 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
EAR CARE
Headlines
Sector Data
Table 70 Sales of Ear Care: Value 2003-2008
Table 71 Sales of Ear Care: % Value Growth 2003-2008
Table 72 Ear Care Company Shares by Value 2004-2008
Table 73 Ear Care Brand Shares by Value 2005-2008
Table 74 Forecast Sales of Ear Care: Value 2008-2013
Table 75 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE
Headlines
Sector Data
Table 76 Sales of Adult Mouth Care: Value 2003-2008
Table 77 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 78 Adult Mouth Care Company Shares by Value 2004-2008
Table 79 Adult Mouth Care Brand Shares by Value 2005-2008
Table 80 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 81 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS
Headlines
Sector Data
Table 82 Sales of Calming and Sleeping Products: Value 2003-2008
Table 83 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 84 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 85 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 86 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 87 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
LABORATOIRES OPALIA TUNISIE
Strategic Direction
Key Facts
Summary 2 Laboratoires Opalia Tunisie: Key Facts
Summary 3 Laboratoires Opalia Tunisie: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 4 Laboratoires Opalia Tunisie: Competitive Position 2008
SOCIETE DES INDUSTRIES PHARMACEUTIQUES DE TUNISIE
Strategic Direction
Key Facts
Summary 5 Société des Industries Pharmaceutiques de Tunisie: Key Facts
Company Background
Production
Competitive Positioning
Summary 6 Société des Industries Pharmaceutiques de Tunisie: Competitive Position 2008
TERIAK LABORATOIRES TUNISIE
Strategic Direction
Key Facts
Summary 7 Teriak Laboratoires Tunisie: Key Facts
Company Background
Production
Summary 8 Teriak Laboratoires Tunisie: Production Statistics 2008
Competitive Positioning
Summary 9 Teriak Laboratoires Tunisie: Competitive Position 2008